Melanoma Persister Cells Are Tolerant to BRAF/MEK Inhibitors via ACOX1-Mediated Fatty Acid Oxidation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Melanoma Persister Cells Are Tolerant to BRAF/MEK Inhibitors via ACOX1-Mediated Fatty Acid Oxidation

Published:2020-11 Issue:8 Volume:33 Page:108421
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Shen Shensi,Faouzi Sara,Souquere Sylvie,Roy Severine,Routier Emilie,Libenciuc Cristina,André Fabrice,Pierron Gérard,Scoazec Jean-Yves,Robert Caroline

Funder

Sébastien Bazin

Fondation Carrefour

INSERM

CNRS

Gustave Roussy

Fondation ARC pour la Recherche sur le Cancer

Institut National Du Cancer

Collectif Ensemble contre le mélanome and Association Vaincre le Mélanome

Les Sites de recherche Intégrés sur le Cancer

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference84 articles.

1. A Fatty Acid Oxidation-dependent Metabolic Shift Regulates the Adaptation of BRAF-mutated Melanoma to MAPK Inhibitors;Aloia;Clin. Cancer Res.,2019

2. Integrated, Step-Wise, Mass-Isotopomeric Flux Analysis of the TCA Cycle;Alves;Cell Metab.,2015

3. Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments;Angelin;Cell Metab.,2017

4. PEX16 contributes to peroxisome maintenance by constantly trafficking PEX3 via the ER;Aranovich;J. Cell Sci.,2014

5. Resistance to BRAF inhibitors induces glutamine dependency in melanoma cells;Baenke;Mol. Oncol.,2016

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of mitochondria and potential of mitochondria-targeted therapy in BRAF mutant cancer: A review;Critical Reviews in Oncology/Hematology;2024-11

2. Cancer drug-tolerant persister cells: from biological questions to clinical opportunities;Nature Reviews Cancer;2024-09-02

3. Multi-omics analysis delineates resistance mechanisms associated with BRAF inhibition in melanoma cells;Experimental Cell Research;2024-09

4. Drug tolerant persister cell plasticity in cancer: a revolutionary strategy for more effective anticancer therapies;Signal Transduction and Targeted Therapy;2024-08-14

5. In vivo vulnerabilities to GPX4 and HDAC inhibitors in drug-persistent versus drug-resistant BRAFV600E lung adenocarcinoma;Cell Reports Medicine;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3